Brain Health
-
FDA Approves Zanvastro, the First Drug for the Rare Brain Disorder Alexander Disease
Madison, October 16 — The US Food and Drug Administration has approved Zanvastro, the first drug designed to directly treat Alexander disease,…
-
Watchdog Finds Pentagon Struggling to Track Troops’ Blast Exposure and Brain Health
WASHINGTON, September 11 — The Pentagon is widening its effort to understand what blast exposure does to service members, and the technical…
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
ROME, July 16 — For decades, dopamine has been shorthand for pleasure in popular culture, the chemical whispered about in connection with…
-
Alzheimer’s Amyloid Beta Explained: How Plaques Form and Two New Blood Tests Detect Them
NEW YORK, July 16 — For the millions of families touched by Alzheimer’s disease, the science can feel impossibly distant. But behind…
-
New Alzheimer’s Drug Kisunla Carries Significant Brain Risk Factors
The U.S. Food and Drug Administration approved Eli Lilly’s monoclonal antibody donanemab, marketed as Kisunla, on July 15, 2024. The drug is…
-
Choline Deficiency Linked to Anxiety and Brain Chemistry
ISLAMABAD, July 10 — A new look at brain imaging data suggests that people with anxiety disorders may have measurably lower levels…
-
Two Antibody Drugs Now Slow Early Alzheimer’s Decline, With Brain-Swelling Risks
WASHINGTON — For the millions of American families touched by Alzheimer’s disease, the past few years have brought something that once felt…
-
Tire chemical linked to new Alzheimer’s risk factor
SAN FRANCISCO — A study published in 2024 in the journal Environmental Health Perspectives has identified a chemical, 6PPD-quinone, as a potential…
-
Modified Vitamin B12 Crosses Blood-Brain Barrier and Targets Glioblastoma in Animal Study
Glioblastoma kills. It kills fast. Most patients get fifteen months, if they’re lucky. Surgery, radiation, chemotherapy — the standard toolkit — rarely…
-
Omega-3 health update after major new study into claims
LOS ANGELES, June 30 — 365 older adults. Two years. Zero measurable brain benefit from fish oil supplements. That is the bottom…
-
High-Dose Fish Oil Shows No Cognitive Benefit in Older Adults at Alzheimer’s Risk
LOS ANGELES — For two years, researchers tracked 365 older adults who took high doses of fish oil. The result, published by…
-
USC study finds fish oil reaches brain but fails to boost cognition in older adults
LOS ANGELES — The omega-3s got to the brain. They just didn’t do anything once they got there. That is the finding…
-
Grey Hair in Your 20s, Foggy Memory in Your 30s: What Neurologists Say About Stress
MANILA, June 28 — For many people across Asia, noticing grey hair in their twenties or struggling with memory in their thirties…
-
Sunlight could be crucial to preventing dementia, study finds
LONDON, June 27 — Getting enough sunlight could be crucial in preventing dementia, a study has found. People who spend, on average,…
-
Cleveland study finds vitamin B12 compound may cross blood-brain barrier to treat glioblastoma
CLEVELAND — Fifteen months. That is the average survival time for a patient diagnosed with glioblastoma. Surgery, radiation, chemotherapy — standard care…
-
Brain Changes Precede Alzheimer’s Plaques by Years, and Memory Awareness Fades Before Dementia
The clock on dementia starts ticking long before the first forgotten name. New research confirms what many in the longevity field have…
-
Kindai University Study: Arginine Cut Alzheimer’s-Linked Amyloid in Mice and Flies
A cheap, widely available dietary supplement may have just given Alzheimer’s research a jolt. Japanese scientists report that arginine, a common amino…
-
Oral Arginine Cuts Amyloid Buildup in Fly and Mouse Models of Alzheimer’s
TOKYO, June 6, 2026 — infopulsetoday.com — Researchers in Japan have made a promising discovery in the fight against Alzheimer’s disease, reporting…
-
Scientists Find Molecular Switch Locking Alzheimer’s Inflammation On
LA JOLLA, June 5 — Researchers at Scripps Research have made a significant discovery in understanding the molecular mechanism behind the chronic…
-
Scripps Research Finds STING Protein Fuels Alzheimer’s Inflammation
LA JOLLA, June 5 — A research team at Scripps Research has identified a specific biochemical alteration that drives chronic inflammation in…
-
Scripps Team Finds Protein Switch Behind Alzheimer’s Brain Inflammation in Mice
A specific chemical alteration to a single protein may be the mechanism that sustains destructive brain inflammation in Alzheimer’s disease, according to…
Most read
-
Martin Lewis Warns Savers With £10,000 or More They Could Owe Tax on Interest
-
Asian & Oceanian Epilepsy Congress 2026 in Kuala Lumpur
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
Axos Offers 5.00% Savings Rate for Six Months After Fed Hike, With Strings Attached
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Understanding Metastatic Prostate Cancer Prognosis and Modern Treatment Pathways
-
Nangibotide Targets Acute-on-Chronic Liver Failure With Phase 2 Data Due 2027
-
SABR Versus Surgery: New Study Reveals Mortality Gap for Early-Stage Lung Cancer
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992